Literature DB >> 20200596

Assessment of Protein Stability in Cerebrospinal Fluid Using Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Protein Profiling.

Srikanth Ranganathan1, Anna Polshyna, Georgina Nicholl, James Lyons-Weiler, Robert Bowser.   

Abstract

Recent studies have evaluated proper acquisition and storage procedures for the use of serum or plasma for mass spectrometry (MS)-based proteomics. The present study examines the proteome stability of human cerebrospinal fluid (CSF) over time at 23°C (room temperature) and 4°C using surface-enhanced laser desorption/ionization time-of-flight MS. Data analysis revealed that statistically significant differences in protein profiles are apparent within 4 h at 23°C and between 6 and 8 h at 4°C. Inclusion of protease and phosphatase inhibitor cocktails into the CSF samples failed to significantly reduce proteome alterations over time. We conclude that MS-based proteomic analysis of CSF requires careful assessment of sample collection procedures for rapid and optimal sample acquisition and storage.

Entities:  

Year:  2006        PMID: 20200596      PMCID: PMC2830664          DOI: 10.1385/CP:2:1:91

Source DB:  PubMed          Journal:  Clin Proteomics        ISSN: 1542-6416            Impact factor:   3.988


  22 in total

1.  Stability of CSF metabolites measured by proton NMR.

Authors:  J Levine; K Panchalingam; S Gershon; J W Pettegrew
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

2.  Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction.

Authors:  John Marshall; Peter Kupchak; Weimin Zhu; Jason Yantha; Tammy Vrees; Shirley Furesz; Kellie Jacks; Chris Smith; Inga Kireeva; Rulin Zhang; Miyoko Takahashi; Eric Stanton; George Jackowski
Journal:  J Proteome Res       Date:  2003 Jul-Aug       Impact factor: 4.466

3.  Performance of quantitative analyses by liquid chromatography-electrospray ionisation tandem mass spectrometry: from external calibration to isotopomer-based exact matching.

Authors:  Thierry Delatour
Journal:  Anal Bioanal Chem       Date:  2004-08-31       Impact factor: 4.142

4.  Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia.

Authors:  Errol R Norwitz; Lawrence C Tsen; Joong Shin Park; Patricia A Fitzpatrick; David M Dorfman; George R Saade; Catalin S Buhimschi; Irina A Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

5.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

6.  Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.

Authors:  Jing Zhang; David R Goodlett; Elaine R Peskind; Joseph F Quinn; Yong Zhou; Qin Wang; Catherine Pan; Eugene Yi; Jimmy Eng; Ruedi H Aebersold; Thomas J Montine
Journal:  Neurobiol Aging       Date:  2005-02       Impact factor: 4.673

7.  Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?

Authors:  Odile Carrette; Pierre R Burkhard; Severine Hughes; Denis F Hochstrasser; Jean-Charles Sanchez
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

8.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

Authors:  Odile Carrette; Isabelle Demalte; Alexander Scherl; Oezkarn Yalkinoglu; Garry Corthals; Pierre Burkhard; Denis F Hochstrasser; Jean-Charles Sanchez
Journal:  Proteomics       Date:  2003-08       Impact factor: 3.984

9.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility.

Authors:  Mark A Rogers; Paul Clarke; Jason Noble; Nicholas P Munro; Alan Paul; Peter J Selby; Rosamonde E Banks
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

10.  Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  Margareta Ramström; Igor Ivonin; Anders Johansson; Håkan Askmark; Karin E Markides; Roman Zubarev; Per Håkansson; Sten-Magnus Aquilonius; Jonas Bergquist
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

View more
  3 in total

1.  Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects.

Authors:  Srikanth Ranganathan; Georgina C B Nicholl; Sarah Henry; Fran Lutka; Ramasri Sathanoori; David Lacomis; Robert Bowser
Journal:  Amyotroph Lateral Scler       Date:  2007-08-03

Review 2.  Applying proteomics to the diagnosis and treatment of ALS and related diseases.

Authors:  Robert Bowser; David Lacomis
Journal:  Muscle Nerve       Date:  2009-11       Impact factor: 3.217

3.  Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children.

Authors:  James M Njunge; Ian N Oyaro; Nelson K Kibinge; Martin K Rono; Symon M Kariuki; Charles R Newton; James A Berkley; Evelyn N Gitau
Journal:  Wellcome Open Res       Date:  2017-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.